{"id":"ce94cf2ec3d2","type":"article","url":"https://hartvaat.nl/2023/12/05/intravasculaire-beeldvorming-versus-functionele-versus-angiografische-pci-begele/","title":"Intravasculaire beeldvorming versus functionele versus angiografische PCI-begeleiding vergeleken","title_en":"Comparison of Intravascular Imaging, Functional, or Angiographically Guided Coronary Intervention.","category":"algemeen","category_label":"Algemeen","professions":["cardioloog"],"tags":["fractional-flow-reserve"],"journal":"Journal of the American College of Cardiology","doi":"10.1016/j.jacc.2023.09.823","source_url":"https://doi.org/10.1016/j.jacc.2023.09.823","authors":["Toshiki Kuno","Yuko Kiyohara","Akiko Maehara","Hiroki A Ueyama","Polydoros N Kampaktsis","Hisato Takagi","Roxana Mehran","Gregg W Stone","Deepak L Bhatt","Gary S Mintz","Sripal Bangalore"],"significance":7,"published":"2023-12-05","source_date":"2023-12-05","image":"","kennis":["https://hartvaat.nl/kennis/coronairlijden/coronaire-angiografie-hartkatheterisatie/","https://hartvaat.nl/kennis/coronairlijden/fractional-flow-reserve/"],"congress":"","summary_en":"This comprehensive meta-analysis compared intravascular imaging, functional testing (FFR/iFR), and angiography-guided PCI, finding that imaging guidance provides the best outcomes, followed by physiological guidance, with angiography alone yielding the worst results.","created":"2026-07-03T10:30:42Z","updated":"2026-07-03T13:29:45Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Uitgebreide meta-analyse vergeleek intravasculaire beeldvorming, functionele testen (FFR/iFR) en angiografie-geleide PCI. Beeldvorming-geleide PCI gaf de beste uitkomsten, gevolgd door functionele testen. Dit versterkt de aanbeveling voor beeldvorming bij PCI.","abstract_original":"BACKGROUND: In patients undergoing percutaneous coronary intervention (PCI), it remains unclear whether intravascular imaging guidance or functional guidance is the best strategy to optimize outcomes and if the results are different in patients with vs without acute coronary syndromes (ACS). OBJECTIVES: The purpose of this study was to evaluate clinical outcomes with imaging-guided PCI or functionally guided PCI when compared with conventional angiography-guided PCI. METHODS: We searched PUBMED and EMBASE for randomized controlled trials investigating outcomes with intravascular imaging-guided, functionally guided, or angiography-guided PCI. The primary outcome from this network meta-analysis was trial-defined major adverse cardiovascular event (MACE)-a composite of cardiovascular death, myocardial infarction (MI), and target lesion revascularization (TLR). PCI strategies were ranked (best to worst) using P scores. RESULTS: Our search identified 32 eligible randomized controlled trials and included a total of 22,684 patients. Compared with angiography-guided PCI, intravascular imaging-guided PCI was associated with reduced risk of MACE (relative risk [RR]: 0.72; 95% CI: 0.62-0.82), cardiovascular death (RR: 0.56; 95% CI: 0.42-0.75), MI (RR: 0.81; 95% CI: 0.66-0.99), stent thrombosis (RR: 0.48; 95% CI: 0.31-0.73), and TLR (RR: 0.75; 95% CI: 0.57-0.99). Similarly, when compared with angiography-guided PCI, functionally guided PCI was associated with reduced risk of MACE and MI. Intravascular imaging-guided PCI ranked first for the outcomes of MACE, cardiovascular death, stent thrombosis, and TLR. The results were consistent in the ACS and non-ACS cohorts. CONCLUSIONS: Angiography-guided PCI had consistently worse outcomes compared with intravascular imaging-guided and functionally guided PCI. Intravascular imaging-guided PCI was the best strategy to reduce the risk of cardiovascular events."}